News tagged ‘BasicResearch’ clear
- Dana-Farber scientists have discovered a molecular switch that enables advanced prostate cancers to spread without stimulation by male hormones, a finding that could serve as a treatment target for castration-resistant prostate cancers.
Tags: BasicResearch, ProstateCancer
- Researchers at Dana-Farber/Children's Hospital Cancer Center have taken the first preliminary steps toward developing a form of gene therapy for sickle cell disease.
- Kornelia Polyak, MD, PhD, was presented with the 2012 AACR Outstanding Investigator Award for Breast Cancer Research at the 35th annual CTRC-AACR San Antonio Breast Cancer Symposium.
Tags: BasicResearch, BreastCancer, Honors
- Scientists at Dana-Farber Cancer Institute have isolated a previously unknown protein in muscles that spurs their growth and increased power following resistance exercise. They suggest that artificially raising the protein’s levels might someday help prevent muscle loss caused by cancer, prolonged inactivity in hospital patients, and aging.
Tags: BasicResearch, Exercise
- Dana-Farber Cancer Institute researchers report findings from a nationwide study that suggest that advanced lung or colorectal cancer patients are frequently mistaken in their beliefs that chemotherapy can cure their disease.
Tags: BasicResearch, EndOfLife
- Dana-Farber scientists have safely shut down breast cancer and a form of leukemia in mice by targeting abnormal proteins to which the cancers are "addicted."
Tags: BasicResearch, BreastCancer, Leukemia
- Dana-Farber researchers have developed a method for determining how ready acute myeloid leukemia cells are to die, a finding that may enable oncologists to choose more effective treatments for their patients.
Tags: BasicResearch, StemCellTransplant, Leukemia
- Dana-Farber researchers have found a genetic signature in tumors to help them determine if diffuse large B cell lymphoma patients will benefit more from traditional therapies or targeted therapies.
Tags: BasicResearch, Lymphoma
- Dana-Farber researchers report that the molecule P5091 triggers cell death in multiple myeloma cancer cells that have become resistant to Velcade.
Tags: BasicResearch, MultipleMyeloma
- The SU2C program, which will feature performances from top recording artists, and celebrities from film, television and sports, will encourage viewers to provide financial support for translational research aimed at accelerating the delivery of new cancer therapies to patients.
Tags: BasicResearch, Grants
Showing 41-50 of 138 items